Omkar Speciality Chemicals is currently trading at Rs. 168.50, up by 4.20 points or 2.56% from its previous closing of Rs. 164.30 on the BSE.
The scrip opened at Rs. 170.85 and has touched a high and low of Rs. 173.20 and Rs. 167.20 respectively. So far 1,19,000 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 249.10 on 13-Jan-2016 and a 52 week low of Rs. 130.05 on 09-Nov-2016.
Last one week high and low of the scrip stood at Rs. 173.20 and Rs. 157.20 respectively. The current market cap of the company is Rs. 347.56 crore.
The promoters holding in the company stood at 53.09%, while Institutions and Non-Institutions held 4.11% and 42.80% respectively.
Omkar Speciality Chemicals has obtained a patent related to the process for preparation of higher derivatives of beta ketoester (B-ketoester) granted by the Government of India. With this, the total number of patents till date granted to the company stands at four. Further, the company has applied for more process patents - some of which are expected in over the next 12-18 months.
Omkar Speciality Chemicals is one of the leading players in the manufacturing of Speciality Chemicals and Veterinary APIs. The company manufactures a range of Organic, Inorganic and Organo Inorganic Intermediates.
| Company Name | CMP |
|---|---|
| BASF India | 3703.10 |
| Tata Chemicals | 709.05 |
| SRF | 2493.65 |
| Pidilite Inds. | 1393.25 |
| Deepak Nitrite | 1538.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: